Clinical Trial Detail

NCT ID NCT02157051
Title Vaccine Therapy in Treating Patients With HER2-Negative Stage III-IV Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors University of Washington
Indications

Her2-receptor negative breast cancer

Therapies
Age Groups: adult

No variant requirements are available.